Glow-in-the-Dark dye could help surgeons spot hidden brain tumors in kids

NCT ID NCT04085887

Recruiting now Diagnosis Sponsor: Stanford University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 2 times

Summary

This study tests a special dye that makes brain tumor cells glow during surgery. The dye is given before surgery, and a special camera helps surgeons see the glowing tumor tissue. The goal is to help surgeons remove more of the tumor while protecting healthy brain tissue. The study includes children and young adults aged 6 months to 25 years who are already scheduled for brain tumor surgery.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: panitumumab-IRDye800 (a dye that attaches to tumor cells to make them glow under a special camera)
What this could lead to: If it works, this could help surgeons remove brain tumors more completely and safely in children, potentially improving outcomes.
What could go wrong: This is an early-phase trial with only 12 participants, so results may not apply to all children. The dye could cause side effects, and it may not make tumors visible enough to change surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BRAIN TUMOR are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

brain cancer brain neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BRAIN TUMOR

Contacts and locations

Locations

Stanford Cancer Center
RECRUITING

Stanford, California, 94304, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.